Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-766]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: IsoSciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTAL INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 15, 2021. Such persons may also file a written request for a hearing on the application on or before March 15, 2021.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA 
                        **Federal Register**
                         Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on November 11, 2020, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002-3420, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleCathinone
1235
IMethcathinone
1237
ILysergic acid diethylamide
7315
IMarihuana
7360
I( print page 3198)Tetrahydrocannabinols
7370
I3,4-Methylenedioxyamphetamine
7400
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
I5-Methoxy-N-N-dimethyltryptamine
7431
IAlpha-methyltryptamine
7432
IBufotenine
7433
IDiethyltryptamine
7434
IDimethyltryptamine
7435
IPsilocybin
7437
IPsilocyn
7438
I5-Methoxy-N,N-diisopropyltryptamine
7439
IDihydromorphine
9145
IHeroin
9200
INicocodeine
9309
INicomorphine
9312
INormorphine
9313
IThebacon
9315
INormethadone
9635
IAcryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide)
9811
IPara-Fluorofentanyl
9812
I3-Methylfentanyl
9813
IAlpha-methylfentanyl
9814
IAcetyl-alpha-methylfentanyl
9815
IN-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
9816
IAcetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
9821
IButyryl Fentanyl
9822
I4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)
9824
I2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
9825
IBeta-hydroxyfentanyl
9830
IBeta-hydroxy-3-methylfentanyl
9831
IAlpha-methylthiofentanyl
9832
I3-Methylthiofentanyl
9833
IFuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)
9834
IThiofentanyl
9835
IBeta-hydroxythiofentanyl
9836
IN-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide
9843
IAmphetamine
1100
IIMethamphetamine
1105
IICodeine
9050
IIDihydrocodeine
9120
IIOxycodone
9143
IIHydromorphone
9150
IIHydrocodone
9193
IIIsomethadone
9226
IIMethadone
9250
IIMethadone intermediate
9254
IIMorphine
9300
IIThebaine
9333
IILevo-alphacetylmethadol
9648
IIOxymorphone
9652
IIThiafentanil
9729
IIAlfentanil
9737
IISufentanil
9740
IICarfentanil
9743
IIFentanyl
9801
II
 The company plans to manufacture bulk controlled substances for use in analytical testing. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator.


[FR Doc. 2021-00647 Filed 1-13-21; 8:45 am] BILLING CODE P